Environmental Enrichment Induces Meningeal Niche Remodeling through TrkB-Mediated Signaling

Int J Mol Sci. 2021 Oct 1;22(19):10657. doi: 10.3390/ijms221910657.

Abstract

Neural precursors (NPs) present in the hippocampus can be modulated by several neurogenic stimuli, including environmental enrichment (EE) acting through BDNF-TrkB signaling. We have recently identified NPs in meninges; however, the meningeal niche response to pro-neurogenic stimuli has never been investigated. To this aim, we analyzed the effects of EE exposure on NP distribution in mouse brain meninges. Following neurogenic stimuli, although we did not detect modification of the meningeal cell number and proliferation, we observed an increased number of neural precursors in the meninges. A lineage tracing experiment suggested that EE-induced β3-Tubulin+ immature neuronal cells present in the meninges originated, at least in part, from GLAST+ radial glia cells. To investigate the molecular mechanism responsible for meningeal reaction to EE exposure, we studied the BDNF-TrkB interaction. Treatment with ANA-12, a TrkB non-competitive inhibitor, abolished the EE-induced meningeal niche changes. Overall, these data showed, for the first time, that EE exposure induced meningeal niche remodeling through TrkB-mediated signaling. Fluoxetine treatment further confirmed the meningeal niche response, suggesting it may also respond to other pharmacological neurogenic stimuli. A better understanding of the neurogenic stimuli modulation for meninges may be useful to improve the effectiveness of neurodegenerative and neuropsychiatric treatments.

Keywords: ANA-12; BDNF; EE; ENR; TrkB; enriched environment; meningeal niche; meninges; neural precursor; neurogenesis; radial glia cell.

MeSH terms

  • Animals
  • Biomarkers
  • Brain-Derived Neurotrophic Factor / metabolism
  • Cellular Microenvironment*
  • Environment*
  • Fluorescent Antibody Technique
  • Fluoxetine / pharmacology
  • Membrane Glycoproteins / metabolism*
  • Meninges / drug effects
  • Meninges / metabolism*
  • Meninges / pathology
  • Mice
  • Neuroglia / metabolism
  • Neurons / metabolism
  • Protein-Tyrosine Kinases / metabolism*
  • Signal Transduction*

Substances

  • Biomarkers
  • Brain-Derived Neurotrophic Factor
  • Membrane Glycoproteins
  • Fluoxetine
  • Ntrk2 protein, mouse
  • Protein-Tyrosine Kinases